PL2945641T3 - Cykloalkinowe pochodne sacharydów - Google Patents
Cykloalkinowe pochodne sacharydówInfo
- Publication number
- PL2945641T3 PL2945641T3 PL14700602T PL14700602T PL2945641T3 PL 2945641 T3 PL2945641 T3 PL 2945641T3 PL 14700602 T PL14700602 T PL 14700602T PL 14700602 T PL14700602 T PL 14700602T PL 2945641 T3 PL2945641 T3 PL 2945641T3
- Authority
- PL
- Poland
- Prior art keywords
- cycloalkine
- saccharid
- derivatives
- saccharid derivatives
- cycloalkine saccharid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1300707.5A GB201300707D0 (en) | 2013-01-15 | 2013-01-15 | Compounds and processes |
| EP14700602.7A EP2945641B1 (en) | 2013-01-15 | 2014-01-13 | Cycloalkyne derivatized saccharides |
| PCT/EP2014/050483 WO2014111344A1 (en) | 2013-01-15 | 2014-01-13 | Cycloalkyne derivatized saccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2945641T3 true PL2945641T3 (pl) | 2020-06-15 |
Family
ID=47758014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14700602T PL2945641T3 (pl) | 2013-01-15 | 2014-01-13 | Cykloalkinowe pochodne sacharydów |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11135300B2 (pl) |
| EP (1) | EP2945641B1 (pl) |
| JP (3) | JP6719209B2 (pl) |
| CN (1) | CN105377282B (pl) |
| BR (1) | BR112015016817B1 (pl) |
| CA (1) | CA2897348C (pl) |
| CY (1) | CY1122822T1 (pl) |
| DK (1) | DK2945641T3 (pl) |
| ES (1) | ES2774729T3 (pl) |
| GB (1) | GB201300707D0 (pl) |
| HR (1) | HRP20200351T1 (pl) |
| LT (1) | LT2945641T (pl) |
| PL (1) | PL2945641T3 (pl) |
| PT (1) | PT2945641T (pl) |
| SI (1) | SI2945641T1 (pl) |
| WO (1) | WO2014111344A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201300707D0 (en) * | 2013-01-15 | 2013-02-27 | Novartis Ag | Compounds and processes |
| CN108697741B (zh) * | 2016-03-04 | 2023-04-14 | 悠绿那股份有限公司 | 抗病毒剂及抗病毒用食品 |
| ES3024474T3 (en) | 2016-12-30 | 2025-06-04 | Vaxcyte Inc | Polypeptide-antigen conjugates with non-natural amino acids |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| JP7295571B2 (ja) * | 2018-02-05 | 2023-06-21 | 国立大学法人 宮崎大学 | 細胞標識剤及び細胞標識キット |
| JP6815561B2 (ja) | 2018-06-14 | 2021-01-20 | 持田製薬株式会社 | 新規な架橋アルギン酸 |
| WO2020010016A1 (en) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Self-adjuvanted immunogenic conjugates |
| JP2023538365A (ja) | 2020-08-19 | 2023-09-07 | バックスサイト・インコーポレイテッド | 担体－タンパク質多糖結合方法 |
| PE20240090A1 (es) * | 2021-05-28 | 2024-01-16 | Pfizer | Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos |
| JP7804631B2 (ja) * | 2022-11-22 | 2026-01-22 | ファイザー・インク | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ535968A (en) * | 2002-03-26 | 2006-08-31 | Chiron S | Modified saccharides having improved stability in water |
| CA2586058A1 (en) | 2004-11-01 | 2006-05-11 | Dennis L. Kasper | Modified streptococcal polysaccharides and uses thereof |
| GB0502095D0 (en) * | 2005-02-01 | 2005-03-09 | Chiron Srl | Conjugation of streptococcal capsular saccharides |
| DK2222341T3 (en) * | 2007-11-21 | 2015-03-09 | Univ Georgia | AND METHODS alkynes of reacting alkynes of 1,3-dipole FUNCTIONAL COMPOUNDS |
| ITVI20090234A1 (it) * | 2009-09-25 | 2011-03-26 | Termotecniche Fraccaro S R L Off | Dispositivo per il riscaldamento di ambienti ad alta efficienza energetica, nonche' sistema riscaldante comprendente tale dispositivo |
| CA2785410A1 (en) * | 2009-12-23 | 2011-06-30 | Carlos F. Barbas, Iii | Tyrosine bioconjugation through aqueous ene-like reactions |
| JP5920936B2 (ja) | 2010-04-27 | 2016-05-18 | シンアフィックス ビー．ブイ． | 縮合シクロオクチン化合物及び無金属クリック反応におけるそれらの使用 |
| WO2012017701A1 (ja) * | 2010-08-05 | 2012-02-09 | 株式会社ミュージックゲート | いびき防止マスク |
| GB201101665D0 (en) * | 2011-01-31 | 2011-03-16 | Novartis Ag | Immunogenic compositions |
| WO2012047663A2 (en) | 2010-09-27 | 2012-04-12 | University Of Georgia Reaserch Foundation, Inc. | Methods including latent 1,3-dipole-functional compounds and materials prepared thereby |
| US20120208722A1 (en) * | 2010-10-19 | 2012-08-16 | Richard Dluhy | Surface enhanced raman spectroscopy platforms and methods |
| DK2721045T3 (en) | 2011-06-20 | 2017-07-24 | Radiomedix Inc | COMPOSITIONS, METHODS OF SYNTHESIS AND USE OF CARBOHYDRATE TARGETED AGENTS |
| RU2014126482A (ru) * | 2011-12-01 | 2016-01-27 | Ангиочем Инк. | Нацеленные соединения ферментов и их применение |
| GB201300707D0 (en) * | 2013-01-15 | 2013-02-27 | Novartis Ag | Compounds and processes |
-
2013
- 2013-01-15 GB GBGB1300707.5A patent/GB201300707D0/en not_active Ceased
-
2014
- 2014-01-13 LT LTEP14700602.7T patent/LT2945641T/lt unknown
- 2014-01-13 CN CN201480012960.8A patent/CN105377282B/zh active Active
- 2014-01-13 BR BR112015016817-5A patent/BR112015016817B1/pt active IP Right Grant
- 2014-01-13 HR HRP20200351TT patent/HRP20200351T1/hr unknown
- 2014-01-13 ES ES14700602T patent/ES2774729T3/es active Active
- 2014-01-13 JP JP2015552077A patent/JP6719209B2/ja active Active
- 2014-01-13 SI SI201431496T patent/SI2945641T1/sl unknown
- 2014-01-13 DK DK14700602.7T patent/DK2945641T3/da active
- 2014-01-13 US US14/760,916 patent/US11135300B2/en active Active
- 2014-01-13 WO PCT/EP2014/050483 patent/WO2014111344A1/en not_active Ceased
- 2014-01-13 EP EP14700602.7A patent/EP2945641B1/en active Active
- 2014-01-13 CA CA2897348A patent/CA2897348C/en active Active
- 2014-01-13 PL PL14700602T patent/PL2945641T3/pl unknown
- 2014-01-13 PT PT147006027T patent/PT2945641T/pt unknown
-
2018
- 2018-12-28 JP JP2018246761A patent/JP2019073528A/ja not_active Withdrawn
-
2020
- 2020-03-13 CY CY20201100223T patent/CY1122822T1/el unknown
- 2020-03-23 JP JP2020050828A patent/JP7036854B2/ja active Active
-
2021
- 2021-05-14 US US17/320,482 patent/US12409231B2/en active Active
-
2025
- 2025-08-08 US US19/294,579 patent/US20260027216A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015016817B1 (pt) | 2020-11-10 |
| EP2945641A1 (en) | 2015-11-25 |
| US12409231B2 (en) | 2025-09-09 |
| JP6719209B2 (ja) | 2020-07-08 |
| BR112015016817A2 (pt) | 2017-07-11 |
| ES2774729T3 (es) | 2020-07-22 |
| CN105377282B (zh) | 2020-07-17 |
| JP2019073528A (ja) | 2019-05-16 |
| CA2897348C (en) | 2022-09-27 |
| US20160166704A1 (en) | 2016-06-16 |
| CY1122822T1 (el) | 2021-05-05 |
| HRP20200351T1 (hr) | 2020-06-12 |
| US20210268116A1 (en) | 2021-09-02 |
| CN105377282A (zh) | 2016-03-02 |
| CA2897348A1 (en) | 2014-07-24 |
| SI2945641T1 (sl) | 2020-03-31 |
| EP2945641B1 (en) | 2020-01-01 |
| JP2016506905A (ja) | 2016-03-07 |
| US11135300B2 (en) | 2021-10-05 |
| JP2020114839A (ja) | 2020-07-30 |
| PT2945641T (pt) | 2020-03-26 |
| DK2945641T3 (da) | 2020-03-09 |
| WO2014111344A1 (en) | 2014-07-24 |
| GB201300707D0 (en) | 2013-02-27 |
| US20260027216A1 (en) | 2026-01-29 |
| JP7036854B2 (ja) | 2022-03-15 |
| BR112015016817A8 (pt) | 2019-10-29 |
| LT2945641T (lt) | 2020-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2025054I1 (no) | Zanidatamab | |
| FIC20240001I1 (fi) | Tislelitsumabi | |
| FIC20240019I1 (fi) | Fetsolinetantti | |
| NO2021043I1 (no) | dostarlima | |
| DK3342773T3 (da) | Syk-hæmmere | |
| DK3613453T3 (da) | Fordamper | |
| HRP20181334T1 (hr) | Samohodno plovilo | |
| DK3077047T3 (da) | Aramcholsalte | |
| DK3052081T3 (da) | Pastil | |
| UY4325S (es) | Otomana | |
| DK3060460T3 (da) | Saddel | |
| DK3027598T3 (da) | Oxoquinazolinyl-butanamidderivater | |
| DK2956698T3 (da) | Bindestrimler | |
| DK2952513T3 (da) | Azolbenzenderivat | |
| PL2945641T3 (pl) | Cykloalkinowe pochodne sacharydów | |
| DK2946640T3 (da) | Langmuir-probe | |
| EP2943489A4 (en) | DEUTERATED MOMELOTINIB | |
| DE102013106534B8 (de) | Chromatographiepipettenspitze | |
| NL301170I2 (nl) | Somatrogon | |
| EP2991647A4 (en) | DEUTERED AMLEXANOX | |
| EP2970310A4 (en) | 5-BROMO-indirubins | |
| EP2853297A4 (en) | kendama | |
| DK3071227T3 (da) | Fiskevaccine | |
| DE112014001252A5 (de) | Aufbissschiene | |
| DK3086679T3 (da) | Sportssko |